Related Experiment Video
Updated: Jan 26, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Exploiting Necroptosis for Therapy of Acute Lymphoblastic Leukemia
Caterina Mezzatesta1, Beat C Bornhauser1
1Department of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
Abstract:
Escape from chemotherapy-induced apoptosis is a hallmark of drug resistance in cancer. The recent identification of alternative programmed cell death pathways opens up for possibilities to circumvent the apoptotic blockade in drug resistant cancer and eliminate malignant cells. Indeed, we have recently shown that programmed necrosis, termed necroptosis, could be triggered to induce cell death in a subgroup of primary acute lymphoblastic leukemia (ALL) including highly refractory relapsed cases. In this review we focus on molecular mechanisms that drive drug resistance in ALL of childhood and discuss the potential of necroptosis activation to eradicate resistant disease.
Insights
Drug-resistant childhood acute lymphoblastic leukemia (ALL) can be targeted using necroptosis, an alternative cell death pathway. Activating necroptosis offers a promising strategy to overcome chemotherapy resistance and eliminate refractory leukemia cells.
Area of Science:
- Oncology
- Molecular Biology
- Cell Death Pathways
Background:
- Chemotherapy resistance in acute lymphoblastic leukemia (ALL) is often linked to the evasion of apoptosis.
- Alternative programmed cell death mechanisms are being explored to overcome apoptotic resistance.
- Necroptosis, a form of programmed necrosis, has emerged as a potential therapeutic target.
Purpose of the Study:
- To review the molecular mechanisms underlying drug resistance in childhood ALL.
- To discuss the potential of activating necroptosis to treat drug-resistant ALL.
- To highlight necroptosis as a strategy to circumvent apoptotic blockade.
Main Methods:
- Literature review focusing on molecular mechanisms of drug resistance in ALL.
- Analysis of studies investigating programmed cell death pathways, including necroptosis.
- Discussion of preclinical and clinical data related to necroptosis induction in leukemia.
Main Results:
- Evasion of apoptosis is a key mechanism of chemotherapy resistance in ALL.
- Necroptosis can be triggered in a subset of primary ALL cells, including refractory cases.
- Targeting necroptosis pathways may offer a novel approach to eliminate resistant leukemia cells.
Conclusions:
- Understanding drug resistance mechanisms in ALL is crucial for developing effective therapies.
- Necroptosis activation presents a promising strategy to overcome chemotherapy resistance in ALL.
- Targeting necroptosis could provide a new avenue for treating refractory childhood ALL.
Related Concept Videos
Gene Therapy
Group Therapy
Psychodynamic Therapy
Humanistic Therapy
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Couples Therapy
Core Principles and Techniques
Couples therapy often incorporates cognitive-behavioral principles to identify and modify negative...

